Meagan Metzger talks to GovernmentCIO Media about her tech accelerator
Newly confirmed CIO Vid Desai discusses how his role has evolved following the creation of FDA's Digital Transformation Office.
The agency's 'batcave' program aims to enact faster development while balancing security and resiliency.
The agency’s Evidence Synthesis Program analyzes large quantities of clinical data to better understand common conditions and provide more effective care to VA patients.
As the IRS nears the mid-point of its six-year modernization plan, the agency's CIO maps out priorities for the future.
CIO Jeff Shilling shares how cloud infrastructure is supporting data-sharing across the cancer research community.
Federal AI leaders share examples of groundwork around data management, training and culture.
The data store is driving personalized and omni-channel experiences for Medicare beneficiaries.
The data chief is aiming to make veteran data integrated across the agency and its partners.
The plan looks to leverage data science and improve health for gender and ethnic minorities.
Artificial intelligence has many promises for efficiency and untapped potential of data, but making it fair and equitable is still a federal challenge.
HHS CAIO Oki Mek said the agency's AI playbook aims to help overcome common challenges around AI adoption.
Agencies must bridge technologists and business leaders to drive successful data strategies.
Leaders at the Center for Tobacco Products outline new research findings for tobacco and cannabis use, following the onset of COVID-19.
Cloud, AI, machine learning and wearables are helping drive agencies' mission and data-driven decision-making.
The service's cyber lead is synchronizing all cyber efforts, ensuring transparency and accelerating change in a new operating environment.
As a founding visionary for its data strategy, Elizabeth Puchek discusses the importance of citizen development for citizenship services.
Medical data experts argue for components behind ethical AI and data use.
NCCIH outlines the potential Brain2AI has for biomedical and behavioral research.
The Vaccine Adverse Events Reporting System quickly detected and alerted federal health agencies on the potentially fatal effects of the Johnson & Johnson COVID-19 vaccine.